Date: 2015-10-28
Type of information: Company acquisition
Acquired company: Medcore (Sweden)
Acquiring company: Karo Bio (Sweden)
Amount: MSEK 18 (€ 1.91 million)
Terms: * On October 28, 2015, Karo Bio acquired more than 90 percent of the shares in MedCore AB. Medocre\'s turnover is approx. MSEK 50 (€ 5.3 million) with an operating profit expected to be slightly positive in 2015. The purchase price is MSEK 18 (€ 1.91 million) . In a first round, Karo Bio pays slightly more than 16 MSEK in new shares for a little more than 90 per cent of the shares in MedCore. Shareholders representing more than 90 per cent of the shares have accepted the offer. After the share issue, a cash offer will be made toremaining shareholders corresponding to the price in the share offer.
Details: MedCore markets primarily licensed medtech products to pharmacies and hospitals in the Nordic region. The products target the therapeutic areas Diabetes, Anesthesia/Intensive Care and Surgery.
Related: diabetes surgery anesthesia
